New research reported today (Wednesday 31 July) at the Alzheimer’s Association International Conference 2024 suggests that eating processed red meat could be a significant risk factor for dementia.
Today (26 July), the European Union’s drugs regulator, the Committee for Medicinal Products for Human Use (CHMP), has advised that the drug lecanemab, a treatment for Alzheimer’s disease, should not be approved for use in the EU.